Science Explorer Back to mapMap
Discussion
Company · Woodcliff Lake · United States

Eagle Pharmaceuticals (United States)

eagleus.comROR OpenAlex
Research works
15
▲ 348% vs 2018-21
Citations
398
26.5 per fractional work
Top-10% rate
8.7%
all institutions 10.0%
Open access
67%
world 40%
International
23%
world 18%
Eagle Pharmaceuticals (United States)

Not ranked overall: Eagle Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Eagle Pharmaceuticals (United States) work in?

In all years, 52% of research at Eagle Pharmaceuticals (United States) is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (50%), Chemistry (14%), Biochemistry, Genetics and Molecular Biology (13%). It does 1.7× the world's share of Health Sciences.

Health Sciences: 8 fractional works · 51.6% of its workMedicine: 8 fractional works · 50.5% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 9.9% of its workEpidemiology: 1 fractional works · 7.1% of its workSurgery: 1 fractional works · 5.8% of its workCritical Care and Intensive Care Medicine: 1 fractional works · 4.1% of its workEmergency Medicine: 0 fractional works · 2.2% of its workInfectious Diseases: 0 fractional works · 2.2% of its workNeurology: 0 fractional works · 2.2% of its workOncology: 0 fractional works · 2.2% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 2.1% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 2.1% of its workGenetics: 0 fractional works · 1.9% of its workHematology: 0 fractional works · 1.7% of its workPhysiology: 0 fractional works · 1.3% of its workComplementary and alternative medicine: 0 fractional works · 1.3% of its workPsychiatry and Mental health: 0 fractional works · 1.1% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.9% of its workOphthalmology: 0 fractional works · 0.7% of its workDermatology: 0 fractional works · 0.5% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.4% of its workHepatology: 0 fractional works · 0.4% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 1.1% of its workGeneral Health Professions: 0 fractional works · 1.1% of its workLife Sciences: 4 fractional works · 24.1% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 12.7% of its workMolecular Biology: 2 fractional works · 11.5% of its workCancer Research: 0 fractional works · 0.7% of its workGenetics: 0 fractional works · 0.4% of its workNeuroscience: 1 fractional works · 9.6% of its workCellular and Molecular Neuroscience: 1 fractional works · 4.5% of its workDevelopmental Neuroscience: 0 fractional works · 2.6% of its workCognitive Neuroscience: 0 fractional works · 2.2% of its workBiological Psychiatry: 0 fractional works · 0.3% of its workImmunology and Microbiology: 0 fractional works · 1.5% of its workApplied Microbiology and Biotechnology: 0 fractional works · 1.5% of its workAgricultural and Biological Sciences: 0 fractional works · 0.4% of its workPlant Science: 0 fractional works · 0.4% of its workPhysical Sciences: 3 fractional works · 22.1% of its workChemistry: 2 fractional works · 14.5% of its workOrganic Chemistry: 2 fractional works · 12.2% of its workPhysical and Theoretical Chemistry: 0 fractional works · 2.2% of its workComputer Science: 1 fractional works · 3.4% of its workComputational Theory and Mathematics: 0 fractional works · 2.9% of its workArtificial Intelligence: 0 fractional works · 0.5% of its workEngineering: 0 fractional works · 2.9% of its workMechanical Engineering: 0 fractional works · 1.5% of its workBiomedical Engineering: 0 fractional works · 0.7% of its workMechanics of Materials: 0 fractional works · 0.7% of its workMaterials Science: 0 fractional works · 1.3% of its workMaterials Chemistry: 0 fractional works · 1.3% of its workSocial Sciences: 0 fractional works · 2.2% of its workPsychology: 0 fractional works · 2.2% of its workSocial Psychology: 0 fractional works · 2.2% of its workALL ITS WORKEaglePharmaceuticals…15fractional works, all years
Life Sciences24%Physical Sciences22%Health Sciences52%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Medicine850.5%
    2. Health Professions01.1%
    1. Biochemistry, Genetics and Molecular Biology212.7%
    2. Neuroscience19.6%
    3. Immunology and Microbiology01.5%
    4. Agricultural and Biological Sciences00.4%
    1. Chemistry214.5%
    2. Computer Science13.4%
    3. Engineering02.9%
    4. Materials Science01.3%
    1. Psychology02.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.62× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 4.78× its world share, 0 worksImmunology and Micro…Neuroscience: 6.30× its world share, 0 worksNeuroscienceComputer Science: 0.19× its world share, 0 worksComputer ScienceEngineering: 0.48× its world share, 0 worksEngineeringHealth Professions: 1.37× its world share, 0 worksHealth ProfessionsMedicine: 3.33× its world share, 3 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 6.3×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Neuroscience6.30×0 works
  2. Immunology and Microbiology4.78×0 works
  3. Medicine3.33×3 works
  4. Biochemistry, Genetics and Molecular Biology1.62×0 works
  5. Health Professions1.37×0 works
  6. Engineering0.48×0 works
  7. Computer Science0.19×0 works

What are the most cited papers from Eagle Pharmaceuticals (United States)?

The most cited paper from Eagle Pharmaceuticals (United States) is "Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial" (David J. Serisier, Diana Bilton, Anthony De Soyza et al., 2013), with 250 citations. Next come "Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient" (155) and "Direct Evaluation of Myocardial Viability and Stem Cell Engraftment Demonstrates Salvage of the Injured Myocardium" (54).

Most cited papers
#PaperReleasedCitations
1 Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial David J. Serisier, Diana Bilton, Anthony De Soyza et al. · Thorax Open access 16 May 2013 250
2 Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient Jennifer L. Harcourt et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 3 Mar 2020 155
3 Direct Evaluation of Myocardial Viability and Stem Cell Engraftment Demonstrates Salvage of the Injured Myocardium Paul J. Kim, Morteza Mahmoudi, Xiaohu Ge et al. · Circulation Research Open access 6 Feb 2015 54
4 Preliminary Evaluation of EVP 1001-1 Pippa Storey, Peter G. Danias, Mark J. Post et al. · Investigative Radiology 26 Sep 2003 44
5 Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice Yun Shi, Lei Zhang, Xue Jun Gao et al. · Journal of Alzheimer s Disease Open access 30 Jun 2020 38
All 26 most cited papers, with filters and sorting

Which research topics does Eagle Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Pneumonia and Respiratory Infections, Nosocomial Infections in ICU, Anesthesia and Neurotoxicity Research and Traumatic Brain Injury and Neurovascular Disturbances.

Pneumonia and Respirator…1Pneumonia and Respiratory Infections: 1 fractional worksNosocomial Infections in…1Nosocomial Infections in ICU: 1 fractional worksAnesthesia and Neurotoxi…0Anesthesia and Neurotoxicity Research: 0 fractional worksTraumatic Brain Injury and Neurovascular Disturbances: 0 fractional worksClostridium difficile and Clostridium perfringens research: 0 fractional worksMitochondrial Function a…0Mitochondrial Function and Pathology: 0 fractional worksPrimary Care and Health Outcomes: 0 fractional worksHelicobacter pylori-related gastroenterology studies: 0 fractional worksEmergency and Acute Care Studies: 0 fractional worksAntibiotic Use and Resistance: 0 fractional works
EpidemiologyCritical Care and Intensive Care MedicineDevelopmental NeuroscienceNeurology6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pneumonia and Respiratory Infections Epidemiology 1 works
  2. 2 Nosocomial Infections in ICU Critical Care and Intensive Care Medicine 1 works
  3. 3 Anesthesia and Neurotoxicity Research Developmental Neuroscience 0 works
  4. 4 Traumatic Brain Injury and Neurovascular Disturbances Neurology 0 works
  5. 5 Clostridium difficile and Clostridium perfringens research Infectious Diseases 0 works
  6. 6 Mitochondrial Function and Pathology Molecular Biology 0 works
  7. 7 Primary Care and Health Outcomes General Health Professions 0 works
  8. 8 Helicobacter pylori-related gastroenterology studies Surgery 0 works
  9. 9 Emergency and Acute Care Studies Emergency Medicine 0 works
  10. 10 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available67.1%not open32.9%

World: 40% of research is openly available.

with international co-authors23.3%domestic only76.7%

World: 18% is written across borders.

How has Eagle Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 348% higher than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Eagle Pharmaceuticals (United States) as a percentage of every work published that year, 0.000010% in 2024.

still counting0.000050%0.00010%0.00015%Eagle Pharmaceuticals (United States)0.000045% in 2025200020102020

Fractional works of Eagle Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Woodcliff Lake

All research institutions in Woodcliff Lake

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Eagle Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.